Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lipoxen | LSE:LPX | London | Ordinary Share | GB00B08NWV55 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.875 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMLPX RNS Number : 9421V Lipoxen PLC 20 July 2009 Lipoxen plc ("Lipoxen" or the "Company") Director dealings The Company was informed on 20 July 2009 that FDS Pharma ("FDS") disposed of 300,000 ordinary shares of 0.5p each ("Ordinary Shares") at 11 pence each on 20 July 2009. FDS director and partner Dr Dimitry D. Genkin is non-executive directors of Lipoxen. Following this disposal he, through FDS, has an interest in Lipoxen of 42,455,316 Ordinary Shares, representing 27.56 per cent of the issued Ordinary Share capital in the Company. Enquires: +-------------------------------------------------+-------------------------+ | Lipoxen plc | +44 (0)20 7691 3583 | +-------------------------------------------------+-------------------------+ | M. Scott Maguire, Chief Executive Officer | | +-------------------------------------------------+-------------------------+ | | | +-------------------------------------------------+-------------------------+ | Singer Capital Markets (nominated adviser) | +44 (0)20 3205 7500 | +-------------------------------------------------+-------------------------+ | Jeff Keating / Claes Spång | | +-------------------------------------------------+-------------------------+ | | | +-------------------------------------------------+-------------------------+ | Noble & Company | +44 (0) 20 7763 2200 | +-------------------------------------------------+-------------------------+ | John Llewellyn-Lloyd / Sam Reynolds | | +-------------------------------------------------+-------------------------+ | | | +-------------------------------------------------+-------------------------+ | Buchanan Communications | +44 (0)20 7466 5000 | +-------------------------------------------------+-------------------------+ | Mary-Jane Elliott, Lisa Baderoon, Rebecca Skye | | | Dietrich, Catherine Breen | | +-------------------------------------------------+-------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END RDSCKKKDKBKDQOB
1 Year Lipoxen Chart |
1 Month Lipoxen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions